PGE1
| SMILES | CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O |
| InChIKey | GMVPRGQOIOIIMI-DWKJAMRDSA-N |
Chemical properties
| Hydrogen bond acceptors | 4 |
| Hydrogen bond donors | 3 |
| Rotatable bonds | 13 |
| Molecular weight (Da) | 354.2 |
Drug properties
| Molecular type | Small molecule |
| Endogenous/Surrogate | Endogenous |
| Approved drug | Yes |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| EP1 | PE2R1 | Mouse | Prostanoid | A | pKi | 7.0 | 7.64 | 8.22 | ChEMBL |
| EP2 | PE2R2 | Mouse | Prostanoid | A | pKi | 7.06 | 7.38 | 7.66 | ChEMBL |
| EP4 | PE2R4 | Mouse | Prostanoid | A | pKi | 8.48 | 8.49 | 8.51 | ChEMBL |
| EP3 | PE2R3 | Mouse | Prostanoid | A | pKi | 8.3 | 8.3 | 8.3 | ChEMBL |
| EP4 | PE2R4 | Mouse | Prostanoid | A | pKi | 8.68 | 8.68 | 8.68 | PDSP Ki database |
| FP | PF2R | Bovine | Prostanoid | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
| DP1 | PD2R | Human | Prostanoid | A | pKi | 7.3 | 7.3 | 7.3 | Guide to Pharmacology |
| EP1 | PE2R1 | Human | Prostanoid | A | pKi | 6.8 | 6.8 | 6.8 | Guide to Pharmacology |
| EP2 | PE2R2 | Human | Prostanoid | A | pKi | 8.04 | 8.04 | 8.04 | Guide to Pharmacology |
| EP4 | PE2R4 | Human | Prostanoid | A | pKi | 8.8 | 8.8 | 8.8 | Guide to Pharmacology |
| IP | PI2R | Human | Prostanoid | A | pKi | 6.86 | 6.86 | 6.86 | PDSP Ki database |
| IP | PI2R | Human | Prostanoid | A | pKi | 6.82 | 6.82 | 6.82 | ChEMBL |
| IP | PI2R | Human | Prostanoid | A | pKi | 6.5 | 6.66 | 6.82 | Guide to Pharmacology |
| EP1 | PE2R1 | Mouse | Prostanoid | A | pKi | 8.09 | 8.09 | 8.09 | Drug Central |
| EP1 | PE2R1 | Mouse | Prostanoid | A | pKi | 7.44 | 7.44 | 7.44 | PDSP Ki database |
| EP1 | PE2R1 | Mouse | Prostanoid | A | pKi | 7.4 | 7.4 | 7.4 | Guide to Pharmacology |
| TP | TA2R | Mouse | Prostanoid | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
| EP3 | PE2R3 | Rat | Prostanoid | A | pKi | 9.0 | 9.0 | 9.0 | Guide to Pharmacology |
| EP3 | PE2R3 | Mouse | Prostanoid | A | pKi | 8.08 | 8.08 | 8.08 | Drug Central |
| EP3 | PE2R3 | Mouse | Prostanoid | A | pKi | 8.96 | 8.96 | 8.96 | PDSP Ki database |
| EP3 | PE2R3 | Mouse | Prostanoid | A | pKi | 9.0 | 9.0 | 9.0 | Guide to Pharmacology |
| EP1 | PE2R1 | Rat | Prostanoid | A | pKi | 8.15 | 8.15 | 8.15 | Drug Central |
| EP1 | PE2R1 | Rat | Prostanoid | A | pKi | 7.0 | 7.0 | 7.0 | Guide to Pharmacology |
| EP2 | PE2R2 | Rat | Prostanoid | A | pKi | 8.1 | 8.1 | 8.1 | Drug Central |
| EP2 | PE2R2 | Rat | Prostanoid | A | pKi | 8.0 | 8.0 | 8.0 | Guide to Pharmacology |
| EP4 | PE2R4 | Rat | Prostanoid | A | pKi | 8.04 | 8.04 | 8.04 | Drug Central |
| EP4 | PE2R4 | Rat | Prostanoid | A | pKi | 9.2 | 9.2 | 9.2 | Guide to Pharmacology |
| EP3 | PE2R3 | Bovine | Prostanoid | A | pKi | 8.4 | 8.55 | 8.7 | PDSP Ki database |
| EP4 | PE2R4 | Mouse | Prostanoid | A | pKi | 8.07 | 8.07 | 8.07 | Drug Central |
| EP4 | PE2R4 | Mouse | Prostanoid | A | pKi | 8.7 | 8.7 | 8.7 | Guide to Pharmacology |
| IP | PI2R | Mouse | Prostanoid | A | pKi | 8.12 | 8.12 | 8.12 | Drug Central |
| IP | PI2R | Mouse | Prostanoid | A | pKi | 6.86 | 7.17 | 7.48 | PDSP Ki database |
| IP | PI2R | Mouse | Prostanoid | A | pKi | 7.5 | 7.5 | 7.5 | Guide to Pharmacology |
| DP1 | PD2R | Rat | Prostanoid | A | pKi | 5.43 | 5.43 | 5.43 | PDSP Ki database |
| EP2 | PE2R2 | Mouse | Prostanoid | A | pKi | 8.12 | 8.12 | 8.12 | Drug Central |
| EP2 | PE2R2 | Mouse | Prostanoid | A | pKi | 8.0 | 8.0 | 8.0 | PDSP Ki database |
| EP2 | PE2R2 | Mouse | Prostanoid | A | pKi | 8.0 | 8.0 | 8.0 | Guide to Pharmacology |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| EP2 | PE2R2 | Mouse | Prostanoid | A | pEC50 | 8.59 | 8.59 | 8.59 | ChEMBL |
| EP4 | PE2R4 | Mouse | Prostanoid | A | pEC50 | 8.44 | 8.55 | 8.6 | ChEMBL |
| DP1 | PD2R | Human | Prostanoid | A | pEC50 | 8.14 | 8.14 | 8.14 | Drug Central |
| EP1 | PE2R1 | Human | Prostanoid | A | pEC50 | 8.17 | 8.17 | 8.17 | Drug Central |
| EP2 | PE2R2 | Human | Prostanoid | A | pEC50 | 8.1 | 8.1 | 8.1 | Drug Central |
| EP3 | PE2R3 | Rat | Prostanoid | A | pEC50 | 8.03 | 8.03 | 8.03 | Drug Central |
| EP3 | PE2R3 | Human | Prostanoid | A | pEC50 | 8.05 | 8.05 | 8.05 | Drug Central |
| EP4 | PE2R4 | Human | Prostanoid | A | pEC50 | 8.06 | 8.06 | 8.06 | Drug Central |
| EP4 | PE2R4 | Human | Prostanoid | A | pEC50 | 9.51 | 9.51 | 9.51 | Guide to Pharmacology |
| IP | PI2R | Human | Prostanoid | A | pEC50 | 8.12 | 8.12 | 8.12 | Drug Central |
| IP | PI2R | Human | Prostanoid | A | pIC50 | 5.85 | 5.85 | 5.85 | ChEMBL |
| IP | PI2R | Human | Prostanoid | A | pEC50 | 8.74 | 8.74 | 8.74 | ChEMBL |
| EP3 | PE2R3 | Rat | Prostanoid | A | pEC50 | 9.35 | 9.35 | 9.35 | Guide to Pharmacology |